Alexion Receives Orphan Drug Status For Dermatomyositis Treatment

The FDA has granted Orphan Drug status to Alexion Pharmaceuticals, Inc.’s humanized monoclonal antibody C5 Complement Inhibitor 5G1.1 for the treatment of patients with dermatomyositis.

Alexion is currently enrolling patients in a Phase Ib pilot clinical trial that is designed to gather clinical data regarding the safety profile and biological and clinical effects of 5G1.1 in this patient population.

The Orphan Drug designation provides Alexion with market exclusivity for seven years from the drug’s approval date.

“Dermatomyositis is a rare and severe inflammatory disorder, the rash and debilitating weakness of which we believe may be alleviated by 5G1.1,” said Leonard Bell, M.D., President and CEO of Alexion.

“We are enthused to work in collaboration with the FDA to as rapidly as possible attempt to provide an innovative therapy for this small, but underserved patient population.

We are continuing to aggressively pursue 5G1.1 in this and other potential orphan indications with the objective of providing relief to multiple underserved and previously unrecognised patient groups.”

Alexion is engaged in the discovery and development of therapeutic products aimed at treating patients with a wide array of severe disease states, including cardiovascular and autoimmune disorders, inflammation and cancer.

Alexion’s two lead product candidates are currently in eight clinical development programs.

5G1.1-SC, in collaboration with Procter & Gamble, is in a Phase IIb cardiopulmonary bypass efficacy trial and in two Phase II myocardial infarction efficacy trials.

Purchasing Dragon Pharma Labs Overseas

Winstrol Tabs - Bulk Price

Administration: Oral
Basic Substance: Stanozolol
Made by: Dragon Pharmaceuticals
Pack: 10 x 100 tabs (50 mg/tablet)
Price: 10 x $63.00


Selective Estrogen Receptor Modulator
Prime Substance: Tamoxifen Citrate
Produced by: Dragon Pharma
Pack: 1 X 100 pills (20 mg/tablet)

Trenbolone 50

Injectable Anabolic Steroid
Principal Component: Trenbolone Suspension
Producer: Dragon Pharma
Package: 1 X 10 mL vial (50 mg/mL)

Trenbolone 100

Injectable Anabolic Steroid
Base Chemical Name: Trenbolone Acetate
Branded by: Dragon Pharmaceuticals
Unit: 1 X 10 ml (100 mg/ml)

EQ 300 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Ingredient: Boldenone Undecylenate
Made by: Dragon Pharmaceuticals
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $42.00 = $420.00 in Total

Parabolan 100 [10 Vials]

Injectable Steroid for Muscle Growth
Prime Substance: Trenbolone Hexahydrobenzylcarbonate
Produced by: Dragon Pharma
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $69.00 = $690.00 in Total

Propionat 100 [10 Vials]

Injectable Steroid for Muscle Growth
Principal Constituent: Testosterone Propionate
Branded by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $30.00 = $300.00 in Total

Deca 300

Injectable Steroid for Muscle Growth
Main Constituent: Nandrolone Decanoate
Manufacturer: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (300 mg/mL)

Parabolan 100

Injectable Steroid for Muscle Growth
Principal Constituent: Trenbolone Hexahydrobenzylcarbonate
Producer: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (100 mg/mL)

Deca 500

Base Substance: Nandrolone Decanoate
Made by: Dragon Pharma Labs
Package: 10 mL vial (500 mg/mL)

Cypionat 250

Principal Component: Testosterone Cypionate
Produced by: Dragon Pharmaceuticals
Unit: 10 x 10 mL vial (250 mg/mL)

Propionat 100

Base Ingredient: Testosterone Propionate
Producer: Dragon Pharma
Pack: 10 x 10 mL vial (100 mg/mL)